Key Takeaway: The article titled 'SCD Safety Summary in AKI' appears to discuss safety aspects related to Sickle Cell Disease (SCD) in patients with Acute Kidney Injury (AKI). However, the content is not accessible as it redirects to a browser check page. Therefore, no detailed information is available from the article.
Price reaction · baseline $66 (2023-09-29 close) · 2 other ICU headline(s) in the window, move may be shared
day 0 close
+58%
day 1 · peak
+123.5%
day 3
+114.5%
Market Sentiment Analysis
Full Press Release Details
Checking your browser before accessing pmc.ncbi.nlm.nih.gov ...
Click
here
if you are not automatically redirected after 5 seconds.